There is a magic when Medical and AI ethics are best friends
Unleashing opportunities for better understanding and collaboration between experts in AI and medical
Unleashing opportunities for better understanding and collaboration between experts in AI and medical
“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
The webinar will provide a snapshot of insights on what matters to patients and how pharma fares in terms of patient centricity based on a new patient centricity benchmarking survey piloted in 2019.
This session describes the National Health Council and opportunities for Medical Affairs professionals to get involved.
J&J leaders detail how to think about managing the challenge of broadening the focus of a Medical Affairs career to encompass new and multiple therapeutic areas.
This MAPS podcast identifies potential areas for compliant collaboration by medical science liaisons with key internal Medical Affairs partners
This webinar reviews the rationale for SoSV as a performance metric in MA, how it is implemented in practice, and examine how it can be used strategically to measure, prioritize and achieve success.
This report shares the key insights from a MAPS special session on Field Medical engagement and provides further context from Medical Affairs colleagues who have first-hand knowledge of the ever-changing Field Medical role.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.